Private Program 'REVOLAX Night in Paris' Held

Hugel, a company specializing in medical aesthetics, announced on February 2 that it participated in the 'IMCAS World Congress 2026,' held in Paris, France from January 29 to 31, together with its hyaluronic acid (HA) filler affiliate, Acros.


IMCAS is the world's largest aesthetic medicine congress and celebrated its 27th edition this year. The event was attended by more than 400 companies and over 20,000 medical professionals and industry representatives from around the world.

Hugel is participating in the 'IMCAS World Congress 2026' to introduce its triangular portfolio. Hugel

Hugel is participating in the 'IMCAS World Congress 2026' to introduce its triangular portfolio. Hugel

View original image

Hugel operated its own booth and showcased its portfolio, which includes the HA filler 'Revolax,' the botulinum toxin 'Letibotulinum,' and the absorbable suture 'Reselvi.' The company prominently featured its product lines, such as fillers, toxins, and sutures.


During the event, Hugel hosted its first private program, 'REVOLAX Night in Paris,' for key partners and medical professionals. This move is seen as a shift from short-term exhibition-focused marketing to strengthening partnerships. About 30 medical professionals and healthcare stakeholders from Europe attended the event.



Hugel also participated in a roundtable discussion on botulinum toxin. Seungjoon Shin, Executive Director of Hugel's Medical Business Division, who served as a panelist, said, "It was an opportunity to further solidify trust in our brand."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing